Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial

被引：0
|
作者：
Hiroaki Seino
机构：
[1] Seino Internal Medical Clinic,
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
Hepatic dysfunction; Luseogliflozin; SGLT2 inhibitor; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：863 / 877
页数：14
相关论文
共 50 条
  • [21] Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
    Boye, Kjetil
    Longhi, Alessandra
    Guren, Tormod
    Lorenz, Susanne
    Naess, Stine
    Pierini, Michela
    Taksdal, Ingeborg
    Lobmaier, Ingvild
    Cesari, Marilena
    Paioli, Anna
    Londalen, Ayca M.
    Setola, Elisabetta
    Hompland, Ivar
    Meza-Zepeda, Leonardo A.
    Hall, Kirsten Sundby
    Palmerini, Emanuela
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2617 - 2624
  • [22] A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
    Hirota, Yushi
    Kakei, Yasumasa
    Imai, Junta
    Katagiri, Hideki
    Ebihara, Ken
    Wada, Jun
    Suzuki, Junichi
    Urakami, Tatsuhiko
    Omori, Takashi
    Ogawa, Wataru
    DIABETES THERAPY, 2024, 15 (02) : 533 - 545
  • [23] A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
    Yushi Hirota
    Yasumasa Kakei
    Junta Imai
    Hideki Katagiri
    Ken Ebihara
    Jun Wada
    Junichi Suzuki
    Tatsuhiko Urakami
    Takashi Omori
    Wataru Ogawa
    Diabetes Therapy, 2024, 15 : 533 - 545
  • [24] Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
    Priscilla K. Brastianos
    Eudocia Quant Lee
    Justine V. Cohen
    Sara M. Tolaney
    Nancy U. Lin
    Nancy Wang
    Ugonma Chukwueke
    Michael D. White
    Naema Nayyar
    Albert Kim
    Christopher Alvarez-Breckenridge
    Ian Krop
    Maura Keeley Mahar
    Mia S. Bertalan
    Brian Shaw
    Joana L. Mora
    Nathaniel Goss
    Megha Subramanian
    Lakshmi Nayak
    Jorg Dietrich
    Deborah A. Forst
    Brian V. Nahed
    Tracy T. Batchelor
    Helen A. Shih
    Elizabeth R. Gerstner
    Beverly Moy
    Donald Lawrence
    Anita Giobbie-Hurder
    Scott L. Carter
    Kevin Oh
    Daniel P. Cahill
    Ryan J. Sullivan
    Nature Medicine, 2020, 26 : 1309 - 1309
  • [25] Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
    Yap, Timothy A.
    Nakagawa, Kazuhiko
    Fujimoto, Nobukazu
    Kuribayashi, Kozo
    Guren, Tormod Kyrre
    Calabro, Luana
    Shapira-Frommer, Ronnie
    Gao, Bo
    Kao, Steven
    Matos, Ignacio
    Planchard, David
    Chatterjee, Arkendu
    Jin, Fan
    Norwood, Kevin
    Kindler, Hedy L.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (06): : 613 - 621
  • [26] Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial
    Zhao, Yi
    Zhang, Xu
    Jin, Chenxing
    Yu, Xiaomin
    Zhang, Min
    Cao, Yang
    Li, Ying
    Wang, Aman
    Shan, Xiu
    Zhang, Jia
    Wang, Juhong
    Yin, Liu
    Tan, Xiaoxin
    Liu, Jiwei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 3277 - 3285
  • [27] Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure
    Fujisue, Koichiro
    Ito, Miwa
    Matsuzawa, Yasushi
    Arima, Yuichiro
    Takashio, Seiji
    Sueta, Daisuke
    Araki, Satoshi
    Hanatani, Shinsuke
    Yamanaga, Kenshi
    Yamamoto, Masahiro
    Kaneko, Shozo
    Yamamoto, Eiichiro
    Matsushita, Kenichi
    Soejima, Hirofumi
    Tsujita, Kenichi
    CIRCULATION REPORTS, 2024, 6 (03) : 55 - 63
  • [28] Safety and Efficacy of Iguratimod in Patients with Active Rheumatoid Arthritis: A Multicenter, Single-Arm, Open-Label, Real World Study
    Mu, Rong
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [29] Evaluation of safety and efficacy of intravenous zanamivir in the treatment of hospitalized Japanese patients with influenza: an open-label, single-arm study
    Watanabe, Akira
    Yates, Phillip J.
    Murayama, Marie
    Soutome, Toru
    Furukawa, Hiroiku
    ANTIVIRAL THERAPY, 2015, 20 (04) : 415 - 423
  • [30] Open-Label, Single-Arm, Exploratory Trial of Opicapone: Status Update of the OASIS (OPICAPONE IN SLEEP DISORDER) Study
    Costa, R.
    Ferreira, J.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2022, 37 : S323 - S323
12345